[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fk4AW_-OjNPcIzHY-lZd1Glz2ShDtb-WTF44VMDwfDSw":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":12,"question":19,"related":20,"source":31,"type":32},[],"2023-11-30 12:19:59",110118713,[8,9,10,11],"特异质反应","变态反应","后遗反应","三致反应",{"count":13,"courseId":14,"courseImg":15,"courseName":16,"workId":17,"workName":18},21,"13a04c1538a7fcf9540d4a9ea124c4a3","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F721b7e32c462c94f0ce6ed9a34f0c126.jpg","临床药物治疗学","956079023d704c829bdbc69b062d2b02","4药物不良放应","少数病人的特异性遗传素质使机体产生的异常药物反应称为",[21,33,43,53,63,66,75,83,93,103],{"answer":22,"createTime":5,"id":23,"options":24,"question":30,"source":31,"type":32},[],110118709,[25,26,27,28,29],"大剂量下出现的不良反应","血药浓度已降至阈浓度以下,仍残存的生物效应","治疗剂量下出现的不良反应","仅发生于个别人的不良反应","突然停药后,原有疾病再次出现并加剧","后遗效应是指","v1",0,{"answer":34,"createTime":5,"id":35,"options":36,"question":42,"source":31,"type":32},[],110118710,[37,38,39,40,41],"治疗量","极量","中毒量","LD50","以上都有可能","可能产生不良反应的剂量是",{"answer":44,"createTime":5,"id":45,"options":46,"question":52,"source":31,"type":32},[],110118711,[47,48,49,50,51],"有合理的时间关系","撤药后不良反应症状消除","再次使用再次出现同样反应","有其他原因或混杂因素干扰","有所用药物ADR的报道和评述","以下&quot;ADR因果关系评价肯定的依据&quot;中,不正确的是",{"answer":54,"createTime":5,"id":55,"options":56,"question":62,"source":31,"type":32},[],110118712,[57,58,59,60,61],"人员联系","不良反应症状消除","发生事件后撤药的结果","是否有其他原因或混杂因素存在","是否已有对所用药物ADR的报道和评述","以下有关&quot;ADR因果关系评价原则&quot;的叙述中,不正确的是",{"answer":64,"createTime":5,"id":6,"options":65,"question":19,"source":31,"type":32},[],[8,9,10,11],{"answer":67,"createTime":5,"id":68,"options":69,"question":74,"source":31,"type":32},[],110118714,[70,71,72,73],"与药物作用无关","潜伏期长","不具重现性","与药物剂量有关","下列属于A型不良反应特点的是",{"answer":76,"createTime":5,"id":77,"options":78,"question":82,"source":31,"type":32},[],110118715,[79,73,80,81],"较为常见","病死率高","可通过减量或停药避免","下列属于B型不良反应特点的是",{"answer":84,"createTime":5,"id":85,"options":86,"question":92,"source":31,"type":32},[],110118716,[87,88,89,90,91],"弥补药品上市前研究的不足","减少ADR的危害","促进临床合理用药","促进新药的研制开发","简化或缩短新药临床试验","对于药物不良反应监测的目的和意义的叙述中,错误的是",{"answer":94,"createTime":5,"id":95,"options":96,"question":102,"source":31,"type":32},[],110118717,[97,98,99,100,101],"有文献资料佐证","停药后反应停止","用药及反应发生时间顺序合理","原患多种疾病混杂因素可能干扰","再次使用反应再现,并明显加重","以下药物不良反应因果关系评定为&quot;肯定&quot;的依据中,错误的是",{"answer":104,"createTime":5,"id":105,"options":106,"question":110,"source":31,"type":32},[],110118718,[107,97,99,108,109],"无重复用药史,基本可排除合并用药导致的可能性","排除原患疾病等其他混杂因素影响","停药后反应停止,再次使用反应再现,并明显加重","ADR因果关系评定为&quot;很可能&quot;的依据中,与&quot;肯定&quot;的依据不同的是"]